Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19

Front Med (Lausanne). 2020 Jul 28;7:453. doi: 10.3389/fmed.2020.00453. eCollection 2020.
No abstract available

Keywords: ARDS (acute respiratory distress syndrome); COVID-19; SARS-CoV-2; TMPRSS2; androgen receptor antagonist; coronavirus; pandemic; spironolactone.